Neuronetics Receives FDA Clearance For Transcranial Magnetic Stimulation System For Depression
About 50% of the 13.9 million people undergoing treatment in the US for major depressive disorder have anxious depression, which represents a large market opportunity for Neuronetics, according to an analyst.
You may also be interested in...
As the global population ages, a crop of tech startups is rising to meet seniors’ needs and improve quality of life, including by keeping them upright and mobile.
The world’s aging, increasingly tech-savvy population has created demand for device and digital health solutions that enable people to live longer, healthier, more independent lives. In this first article of a three-part series on Agetech, we highlight innovative telehealth companies that are making impacts by going beyond primary clinical needs to address mental health, quality of life, and underserved patients.
Amazon’s planned acquisition of One Medical will dramatically expand their brick-and-mortar footprint, accelerating its growth, according to a health care consultant.